Delivery Order SPE2DB22D3011-SPE2DB26FP7HD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,248.18 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100, with an ultimate completion date of July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger contract vehicle. The pharmaceuticals will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,179.40 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,331.08 for Ambien CR 6.25 mg tablets (100-count units) on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The pharmaceutical distributor will perform the delivery order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a competitive delivery order valued at $2,441.34 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packaging) on October 22, 2025, with completion targeted for October 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,559.10 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,610.42 to AmerisourceBergen Drug Corp for Ambien CR 6.25 mg tablets (100-count units), with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,076.82 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). The contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a competitively awarded, non-set-aside transaction with firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packaging) on August 13, 2025, with a ceiling value of $1,715.50 and an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,841.30 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract. The award, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-competitive delivery order executed without set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,890.69 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of the company's pharmaceutical supply services to federal medical procurement needs. The place of performance is AmerisourceBergen's...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB26FP7HDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,178.36 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The order is scheduled for completion by October 29, 2025, with fulfillment originating from the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. As a non-set-aside award, this delivery order reflects the contractor's demonstrated capability to compete for federal pharmaceutical supplies across multiple therapeutic domains. The DLA's engagement of AmerisourceBergen through its broader Pharmaceutical Prime Vendor Global Program vehicle enables efficient sourcing of essential medications to support Defense Health Agency operations and other government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 10/28/25 |